ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,334Medicare Part D Prescriptions Filled, Including Refills

Rank: 131 out of 2035

$560K Total Retail Price of All Prescriptions

Rank: 241 out of 2035

636 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 636 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 9,564 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 631 532 1 4
LISINOPRIL 540 465 2 3
SIMVASTATIN 525 485 3 1
AMLODIPINE BESYLATE 379 318 4 6
OMEPRAZOLE 354 271 5 5
METOPROLOL SUCCINATE 330 302 6 16
ATENOLOL 312 290 7 10
ALENDRONATE SODIUM 305 274 8 27
HYDROCODONE-ACETAMINOPHEN 284 220 S3 9 2
CITALOPRAM HBR 220 172 10 20
ZOLPIDEM TARTRATE 204 170 11 21
WARFARIN SODIUM 184 153 12 11
LOVASTATIN 179 162 13 33
FUROSEMIDE 176 143 14 7
TAMSULOSIN HCL 160 140 15 25
ATORVASTATIN CALCIUM 153 136 16 13
HYDROCHLOROTHIAZIDE 147 145 17 12
SERTRALINE HCL 126 115 18 23
DOXAZOSIN MESYLATE 126 118 18 111
METOPROLOL TARTRATE 125 125 20 8
ALLOPURINOL 124 99 21 34
POTASSIUM CHLORIDE 124 101 21 18
GABAPENTIN 104 85 23 14
FLUOXETINE HCL 103 76 24 81
TRAMADOL HCL 102 86 25 19
CARVEDILOL 98 75 26 22
METFORMIN HCL 92 82 27 9
PRAVASTATIN SODIUM 92 88 27 17
EVISTA 83 83 29 136
TRIAMTERENE-HCTZ 83 71 29 35
FLUTICASONE PROPIONATE 82 59 31 29
LOSARTAN POTASSIUM 77 77 32 15
CLOPIDOGREL 69 65 33 30
ALPRAZOLAM 69 67 33 109
GLIMEPIRIDE 66 66 35 55
VERAPAMIL ER 64 47 36 115
DIOVAN 64 61 36 76
LANSOPRAZOLE 63 63 38 118
METFORMIN HCL ER 62 61 39 78
BENAZEPRIL HCL 61 58 40 128
ACETAMINOPHEN-CODEINE 60 58 S3 41 52
PRAMIPEXOLE DIHYDROCHLORIDE 59 51 42 220
PANTOPRAZOLE SODIUM 59 57 42 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 54 44 26
NABUMETONE 58 37 44 190
RANITIDINE HCL 57 53 46 28
PREDNISONE 57 47 46 36
TEMAZEPAM 56 56 48 455
ADVAIR DISKUS 54 53 49 38
NAMENDA 53 53 50 37
FAMOTIDINE 51 44 51 71
PLAVIX 51 46 51 49
DONEPEZIL HCL 50 47 53 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.